IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q2 2021 Results - Earnings Call Transcript

ImmunoGen, Inc. (IMGN) Q2 2021 Earnings Conference Call July 30, 2021, 08:00 ET Company Participants Courtney O’Konek - Senior Director, Corporate Communications & IR Mark Enyedy - President, CEO & Director Anna Berkenblit - SVP & Chief Medical Officer Susan Altschuller - SVP & CFO Conference Call Participants John Newman - Canaccord Genuity Yige Guo - Guggenheim Securities Boris Peaker - Cowen and Company Swayampakula Ramakanth - H.C. Wainwright & Co. Andy Hsieh - William Blair & Company Kelly Shi - Jefferies Joseph Catanzaro - Piper Sandler & Co. Daniel Wolle - JPMorgan Chase & Co. Presentation Operator Good morning, and welcome to the ImmunoGen Second Quarter 2021 Financial and Operating Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Courtney O'Konek, Senior Director of Corporate Communications and Investor Relations. Please go ahead. Courtney O’Konek Good morning, and thank you

For further details see:

ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q2 2021 Results - Earnings Call Transcript